NCT04794283

Brief Summary

The project is a descriptive cohort study with a retrospective and a prospective group where pregnancy and childbirth data will be studied. Mothers with DM1, DM2, GDM hand-milk 2 times/day from v.36+0, freeze the colostrum they receive and bring it to delivery ward. The colostrum will then be given instead of milk substitutes for their children postpartum. The primary questions are whether there is any statistical difference between a group that provides only colostrum compared to an equal retrospective group, which has only been given milk substitutes, in the case of neonatal hypoglycemia in the first 24 hours postpartum. Secondly: 10 healthy women and 10women with DM1 will provide analysis of colostrum at week 36 of pregnancy. The secondary question is if there is any differences in colostrum whether the mother is healthy or has DMtype1

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
186

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 12, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

March 1, 2021

Last Update Submit

March 28, 2022

Conditions

Keywords

Diabetes type1Diabetes type2GDM

Outcome Measures

Primary Outcomes (1)

  • neonatal hypoglycemia on day 0 of life will be meassured

    The child's blood sugar levels in the first day of life (at least three occasions). \- the number of occasions of hypoglycemia in the child in the first 24 hours (limit value \<2,6 mmol/L),

    day 0

Secondary Outcomes (1)

  • Hyperbilirubinemia during the first week of life will be meassured

    First week of life

Study Arms (2)

Hand milking with Diabetes

93 women with DM1, DM2 and medically treated GDM who are patients in specialist maternity care at Soderhospital in Stockholm and who plan to hand milk are part of this group.

Other: Breast milk

Not hand milking with diabetes

A group of 93 women are then selected from 1 April 2021and back in the same number as the group1 (n=93) this group only gave milk substitute the first 24h.

Interventions

Milk substitute given during the first 24h

Also known as: Milksubstitute
Hand milking with Diabetes

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Pregnant women with diabetes

You may qualify if:

  • Pregnant women with DM1, DM2 and medically treated GDM
  • Women must:
  • Be patients in specialist maternity care at the hospital
  • Plan to hand milk during pregnancy
  • Start at 36w of gestation

You may not qualify if:

  • women who don't have diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eva Wiberg-Itzel

Stockholm, 18239, Sweden

Location

Related Publications (1)

  • Monemi E, Tingstrom J, Sterpu I, Wiberg-Itzel E. The impact of lowering the blood glucose cut-off values in gestational diabetes mellitus on maternal and perinatal outcomes. Eur J Obstet Gynecol Reprod Biol. 2025 Apr;307:43-48. doi: 10.1016/j.ejogrb.2025.01.031. Epub 2025 Jan 22.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

Milk, Human

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

MilkBeveragesDiet, Food, and NutritionPhysiological PhenomenaDairy ProductsFoodFood and Beverages

Study Officials

  • Eva Wiberg-Itzel, Profeesor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 12, 2021

Study Start

March 1, 2021

Primary Completion

March 1, 2022

Study Completion

March 1, 2023

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations